<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref16">
 <mixed-citation publication-type="journal" id="cit16">
  <name>
   <surname>Pillaiyar</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Manickam</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Namasivayam</surname>
   <given-names>V.</given-names>
  </name>; 
  <name>
   <surname>Hayashi</surname>
   <given-names>Y.</given-names>
  </name>; 
  <name>
   <surname>Jung</surname>
   <given-names>S. H.</given-names>
  </name>
  <article-title>An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule Chemotherapy</article-title>. 
  <source>J. Med. Chem.</source>
  <year>2016</year>, 
  <volume>59</volume> (
  <issue>14</issue>), 
  <fpage>6595</fpage>â€“
  <lpage>628</lpage>. 
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01461</pub-id>.
  <pub-id pub-id-type="pmid">26878082</pub-id>
 </mixed-citation>
</ref>
